Renate Panzer‐Grümayer

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

Valentino Conter, Claus R. Bartram, Maria Grazia Valsecchi et al. · Blood · 2010 · 786 citations · Full text

Medicine, Hematology, Oncology +11

Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

Martin Schrappe, Maria Grazia Valsecchi, Claus R. Bartram et al. · Blood · 2011 · 438 citations · Full text

Life Sciences, Immunology, Immunotherapy +3

<i>IKZF1</i>^plusDefines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

Martin Stanulla, Elif Dağdan, Markéta Žaliová et al. · Journal of Clinical Oncology · 2018 · 299 citations

Life Sciences, Genetics, Oncology +17

Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia

Sarah Ebinger, Erbey Ziya Özdemir, Christoph Ziegenhain et al. · Cancer Cell · 2016 · 282 citations · Full text

Medicine, Cell Biology, Oncology +14

Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options

Ute Fischer, Michael Förster, Anna Maria Rinaldi et al. · Nature Genetics · 2015 · 253 citations · Full text

Medicine, Molecular Biology, Oncology +16